Participants 31 67 4
patients with cirrhosis and ascites.
Participants 224 272 6
seven patients with cirrhosis and tense ascites.
Participants 273 395 3
Patients also received a low-sodium (40 mmol/day) diet and the aldosterone antagonist, potassium canrenoate (100 mg b.i.d.
Participants 998 1087 3
is suitable for the treatment of sodium retention in patients with cirrhosis and ascites.
